No standard treatment has been established for metastatic uveal melanoma (mUM). Immunotherapy is commonly used for this disease even though UM has not been included in phase III clinical trials with checkpoint inhibitors. Unfortunately, only a minority of patients obtain a clinical benefit with immunotherapy. The immunological features of mUM were reviewed in order to understand if immunotherapy could still play a role for this disease.

Rossi, E., Schinzari, G., Zizzari, I. G., Maiorano, B. A., Pagliara, M. M., Sammarco, M. G., Fiorentino, V., Petrone, G., Cassano, A., Rindi, G., Bria, E., Blasi, M. A., Nuti, M., Tortora, G., Immunological backbone of uveal melanoma: Is there a rationale for immunotherapy?, <<CANCERS>>, 2019; 11 (8): 1055-1066. [doi:10.3390/cancers11081055] [http://hdl.handle.net/10807/147729]

Immunological backbone of uveal melanoma: Is there a rationale for immunotherapy?

Rossi E.;Schinzari G.;Maiorano B. A.;Pagliara M. M.;Fiorentino V.;Petrone G.;Cassano A.;Rindi G.;Bria E.;Blasi M. A.;Tortora G.
2019

Abstract

No standard treatment has been established for metastatic uveal melanoma (mUM). Immunotherapy is commonly used for this disease even though UM has not been included in phase III clinical trials with checkpoint inhibitors. Unfortunately, only a minority of patients obtain a clinical benefit with immunotherapy. The immunological features of mUM were reviewed in order to understand if immunotherapy could still play a role for this disease.
eng
https://www.mdpi.com/2072-6694/11/8/1055/pdf
Rossi, E., Schinzari, G., Zizzari, I. G., Maiorano, B. A., Pagliara, M. M., Sammarco, M. G., Fiorentino, V., Petrone, G., Cassano, A., Rindi, G., Bria, E., Blasi, M. A., Nuti, M., Tortora, G., Immunological backbone of uveal melanoma: Is there a rationale for immunotherapy?, <>, 2019; 11 (8): 1055-1066. [doi:10.3390/cancers11081055] [http://hdl.handle.net/10807/147729]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/10807/147729
Citazioni
  • ???jsp.display-item.citation.pmc??? 14
  • Scopus 21
  • ???jsp.display-item.citation.isi??? 20
social impact